Mounjaro Long-Term Use: What the Evidence Shows (October 2026)

01 · The core answer

Can you use Mounjaro long term?

Mounjaro is licensed in the UK for weight management in adults and for type 2 diabetes.¹ It is used alongside a reduced-calorie diet and increased physical activity.¹

In practice, the decision is reviewed over time. A prescriber looks at how you are responding, whether side effects are manageable, and whether your health goals are being met. That is why ongoing monthly reviews matter more than any single number of months.

For more on this topic, see our guide on whether Mounjaro is safe over the long run.

02 · Evidence

What the long-term evidence actually covers

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.² These are trial averages, and individual results vary.

Our page on long-term studies on Mounjaro explains how to read this kind of research.

03 · Your decision

What to decide next

The useful question is not "how long can I stay on it?" but "is it still doing its job for me, safely?" If you are weighing up starting, our weight loss clinic explains the pathway. If you are ready to look at the medicine itself, you can see current doses and costs on the Mounjaro pen page.

04 · Staying on treatment

How ongoing treatment works in practice

Ongoing treatment means regular check-ins rather than a one-off prescription. Mounjaro comes as a once-weekly pre-filled KwikPen in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹ Everyone starts on 2.5mg once a week; after at least 4 weeks the dose can increase, depending on how you respond and tolerate it, and your prescriber guides the pace. If you step up after 4 weeks on each of 2.5mg, 5mg, 7.5mg and 10mg, your first four pens cost £879.96 at standard prices; a new customer's first order is £40 less and every later order £25 less.

Your long-term dose is not necessarily the highest one. The trial figures show results at 5mg, 10mg and 15mg, all of which are averages across people who responded differently.² The right dose is the one that works for you with side effects you can manage, agreed with your prescriber.

At EverydayMeds, repeat orders re-check suitability and there is no auto-shipping, so you stay in control of each order. Our aftercare includes ongoing monthly reviews, dose-titration and follow-up assessments by the prescribing team, plus side-effect support.

05 · If you stop

What happens if you stop Mounjaro

When you stop, tirzepatide leaves your system over four to five weeks, and nothing needs doing while it clears.¹ The half-life is about five days, and there is no way to speed the process up.¹

Tirzepatide activates the GIP and GLP-1 receptors, which help regulate appetite and slow how quickly the stomach empties.¹ Once it has cleared, those effects are no longer there. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.

If you are thinking of stopping, talk to your prescriber about how to keep up the diet and activity habits you have built. Our guide on the long-term benefits of Mounjaro covers what people hope to keep.

06 · Long-term safety

Long-term safety and side effects

Serious side effects are uncommon but need urgent attention, and they are worth knowing from day one. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin or eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.¹

If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion). Your prescriber may need to adjust those medicines.¹

Report any suspected side effect through the Yellow Card scheme.¹⁹ Our pages on side effects of long-term Mounjaro use and Mounjaro risks over time go through them in more detail.

07 · Thyroid, kidneys, mood

Thyroid, kidneys, liver and mood over time

In rodent studies tirzepatide caused thyroid C-cell tumours; it is not known whether this applies to humans, and no increase has been shown in human trials.¹ Tell your prescriber if you or a close relative have had medullary thyroid cancer or the inherited condition MEN 2. Routine thyroid monitoring is not required for most people.¹

Mounjaro is not known to damage kidneys or liver directly, and no dose adjustment is needed for mild to moderate kidney or liver impairment.¹ The practical risk is indirect: severe vomiting or diarrhoea can cause dehydration, which can strain the kidneys. Keep fluids up and get medical help straight away if you cannot keep fluids down.¹

On mood, the EMA's safety committee reviewed the evidence and concluded in 2024 that it does not support a causal link between GLP-1 medicines and suicidal thoughts, and the MHRA keeps this under continuous review.¹⁷ Even so, big changes in weight, appetite and routine can affect how you feel. Seek help promptly if your mood drops. Our guide to the long-term effects of Mounjaro covers this further.

If you have thoughts of harming yourself or ending your life, get help straight away. Call 999 or go to A&E if you are in immediate danger. In England you can call NHS 111 and choose the mental health option, any time. You can also call Samaritans free on 116 123, day or night. Tell your prescriber about any change in your mood while taking Mounjaro.

08 · Who should not use it

Who should not take Mounjaro

Mounjaro is not suitable for everyone, and suitability is rechecked over time. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive.¹³ Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.

Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems. Always share your full medical history and medicine list.¹³

09 · Beyond the scales

Why prescribers think beyond weight

In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.² These are trial-average secondary outcomes, not promises, but they are why prescribers talk about weight management as health management rather than appearance.

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the primary-care rollout began in June 2025 with the highest-need groups first.⁴ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.